PCSA insider transaction filings
Processa Pharmaceuticals, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-11. Screen PCSA transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 19 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings by 5 insiders — 13,407 shares, $25,876 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: purchase of 3,277 shares @ $1.93 ($6,325) by SKIBSTED RUSSELL, filed 2026-07-01.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| SKIBSTED RUSSELL — Chief Financial Officer | 2 | 1 leg · 3,277 sh · $6,325 | — | 1 |
| Ng George K — Chief Executive Officer, Director | 3 | 1 leg · 3,057 sh · $5,900 | — | 3 |
| Young David — Pres. Research & Development, Director | 1 | 1 leg · 2,531 sh · $4,885 | — | — |
| Guy Wendy — Chief Administrative Officer | 2 | 1 leg · 2,436 sh · $4,701 | — | 1 |
| Lin Patrick — Chief Business - Strategy Off | 2 | 1 leg · 2,106 sh · $4,065 | — | 1 |
| Baluch Khoso — Director | 2 | — | — | 3 |
| Neal James R — Director | 2 | — | — | 3 |
| Pannu Geraldine — Director | 2 | — | — | 3 |
| Yorke Justin W — Director | 2 | — | — | 3 |
| GUJRATHI SHEILA — Director | 1 | — | — | 2 |
Recent Form 4 filings — Processa Pharmaceuticals, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-11 | 4 | Ng George K — Chief Executive Officer, Director | Option exercise (M): 1,600 · Option exercise (M): 1,600 (derivative) @ $0 | EDGAR |
| 2026-07-30 | 4 | GUJRATHI SHEILA — Director | Grant/award (A): 70,811.88 (derivative) · Grant/award (A): 12,311.28 (derivative) | EDGAR |
| 2026-07-28 | 4 | Yorke Justin W — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Grant/award (A): 11,883 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Pannu Geraldine — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Ng George K — Chief Executive Officer, Director | Grant/award (A): 9,384 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Lin Patrick — Chief Business - Strategy Off | Grant/award (A): 8,450 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Neal James R — Director | Grant/award (A): 62,221 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Guy Wendy — Chief Administrative Officer | Grant/award (A): 9,450 (derivative) @ $0 | EDGAR |
| 2026-07-28 | 4 | Baluch Khoso — Director | Grant/award (A): 33,500 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 2,436 @ $1.93 | EDGAR |
| 2026-07-01 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 2,106 @ $1.93 | EDGAR |
| 2026-07-01 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 3,057 @ $1.93 | EDGAR |
| 2026-07-01 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 2,531 @ $1.93 | EDGAR |
| 2026-07-01 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 3,277 @ $1.93 | EDGAR |
| 2026-06-30 | 4 | Pannu Geraldine — Director | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Neal James R — Director | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Baluch Khoso — Director | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Yorke Justin W — Director | Option exercise (M): 203 · Option exercise (M): 203 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 2,465 @ $2.22 | EDGAR |
| 2026-06-16 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 1,831 @ $2.22 | EDGAR |
| 2026-06-16 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 2,118 @ $2.22 | EDGAR |
| 2026-06-16 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 2,067 @ $2.22 | EDGAR |
| 2026-06-16 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 2,654 @ $2.22 | EDGAR |
| 2026-06-01 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 2,129 @ $2.57 | EDGAR |
| 2026-06-01 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 1,582 @ $2.57 | EDGAR |
| 2026-06-01 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 1,829 @ $2.57 | EDGAR |
| 2026-06-01 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 1,786 @ $2.57 | EDGAR |
| 2026-06-01 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 2,292 @ $2.57 | EDGAR |
| 2026-05-19 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 1,843 @ $2.97 | EDGAR |
| 2026-05-19 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 1,369 @ $2.97 | EDGAR |
| 2026-05-19 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 1,583 @ $2.97 | EDGAR |
| 2026-05-19 | 4/A | Ng George K — Chief Executive Officer, Director | Purchase (P): 1,843 @ $2.97 | EDGAR |
| 2026-05-19 | 4/A | Bigora Sian — Chief Development Officer | Purchase (P): 1,971 @ $2.71 | EDGAR |
| 2026-05-19 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 1,545 @ $2.97 | EDGAR |
| 2026-05-19 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 1,984 @ $2.97 | EDGAR |
| 2026-05-01 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 2,034 @ $2.69 | EDGAR |
| 2026-05-01 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 1,511 @ $2.69 | EDGAR |
| 2026-05-01 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 1,748 @ $2.69 | EDGAR |
| 2026-05-01 | 4 | Bigora Sian — Chief Development Officer | Purchase (P): 1,986 @ $2.69 | EDGAR |
| 2026-05-01 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 1,706 @ $2.69 | EDGAR |
| 2026-05-01 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 2,190 @ $2.69 | EDGAR |
| 2026-04-30 | 4/A | Ng George K — Chief Executive Officer, Director | Purchase (P): 1,843 @ $2.97 | EDGAR |
| 2026-04-30 | 4/A | Ng George K — Chief Executive Officer, Director | Purchase (P): 2,136 @ $2.54 | EDGAR |
| 2026-04-17 | 4 | Ng George K — Chief Executive Officer, Director | Purchase (P): 1,843 @ $2.97 | EDGAR |
| 2026-04-17 | 4 | Lin Patrick — Chief Business - Strategy Off | Purchase (P): 1,369 @ $2.97 | EDGAR |
| 2026-04-17 | 4 | Guy Wendy — Chief Administrative Officer | Purchase (P): 1,583 @ $2.97 | EDGAR |
| 2026-04-17 | 4 | Bigora Sian — Chief Development Officer | Purchase (P): 1,799 @ $2.97 | EDGAR |
| 2026-04-17 | 4 | Young David — Pres. Research & Development, Director | Purchase (P): 1,545 @ $2.97 | EDGAR |
| 2026-04-17 | 4 | SKIBSTED RUSSELL — Chief Financial Officer | Purchase (P): 1,984 @ $2.97 | EDGAR |
Recent 8-K events — Processa Pharmaceuticals, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-16 | 8-K/A | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-09-02 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PCSA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →